Friday, April 29, 2016

Sanofi CEO Seeks Talks With Medivation Over $9.3 Billion Offer

Medivation, a Nasdaq-listed company that focuses on hard-to-treat cancers, has rebuffed a takeover approach by the French drugmaker.

from WSJ.com: US Business http://ift.tt/1NZrA7f
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)